Ewing Morris & Co. Investment Partners Ltd. Royalty Pharma PLC Transaction History
Ewing Morris & Co. Investment Partners Ltd.
- $157 Million
- Q2 2025
A detailed history of Ewing Morris & Co. Investment Partners Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ewing Morris & Co. Investment Partners Ltd. holds 28,522 shares of RPRX stock, worth $1.03 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
28,522Holding current value
$1.03 Million% of portfolio
0.65%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
497Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.68 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$830 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$789 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$650 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...